Retasturtide is a recently introduced novel GLP-1 receptor agonist demonstrating substantial results in the treatment of type 2 diabetes. This synthetic peptide duplicates the actions of naturally produced GLP-1, a https://neilpskg683192.activosblog.com/37819381/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes